Stockreport

First-Of-Its-Kind Independent Study Finds SmartVest® Reduces Exacerbations, Antibiotic Use, and Stabilizes Lung Function as Part of a Treatment Algorithm

Electromed, Inc.  (ELMD) 
NASDAQ:AMEX Investor Relations: smartvest.com/electromed/investor-relations
PDF NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (NYSE American: ELMD) today announced that a new, first-of-its-kind study published in BMC Pulmonary Medicine fo [Read more]